Preview Mode Links will not work in preview mode

Pharmacy Podcast Network


Pharmacy Podcast Network (PPN) is a first in the history of podcasting and the pharmacy industry as the first network dedicated to the pharmacist professional about the business of pharmacy. 25+ podcast channels and 70,000+ listeners with 30+ podcast co-hosts, the PPN is the leading the healthcare space worldwide as the most influential podcast network. 

The PPN started in 2009 in Pittsburgh, PA by Pharmacy Business  Entrepreneur Todd S. Eury. Eury has gathered the brightest minds in pharmacy to create a viral network of podcasting intelligence. 

Partnering with RXVIP Enterprises for pharmacist provider patient care strategies to deliver more healthcare services and saving lives. The 1st Internet Radio station in the pharmacy industry with Helium Radio headquartered in Tampa FL. 

Feb 19, 2013

ADAM J. FEIN, PH.D.

Drug Channels was created and is written by Adam J. Fein, Ph.D., one of the country’s foremost experts on pharmaceutical economics and channel strategy. The president of Pembroke Consulting, Inc., and CEO of Drug Channels Institute, Dr. Fein consults with clients in the pharmaceutical and healthcare industries. Eleven of the 15 largest biopharmaceutical manufacturers have relied upon Dr. Fein for his experience, analyses, and insights to help them improve profitability and make better strategic decisions. Click here to read more about Dr. Fein’s industry presence.

Dr. Fein excels at unlocking and explaining complex business and economic issues with humor and an accessible, straightforward style, making Drug Channels a popular and authoritative destination for both industry insiders and outsiders. Drug Channels has been cited in such media outlets as The Wall Street Journal and Drug Benefit News, in academic research papers, and across other industry websites.

OUR READERS

A leader in the pharmaceutical economics blogosphere, Drug Channels has a loyal following of engaged readers. Drug Channels attracts a large, unique, diverse audience throughout the pharmaceutical and healthcare industries. 

Our readers’ backgrounds reflect the many diverse topics that Drug Channels reports and analyzes. We offer free subscriptions via emailRSS feed, or Twitter. As of January 2013, Drug Channels has nearly 6,000 subscribers via these methods. All articles are also shared with the more than 900 people on Dr. Fein’s personal LinkedIn account. Many key healthcare industries are represented in our readership.